Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 2.02 CAD 0.5%
Market Cap: 55.4m CAD

Covalon Technologies Ltd
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Covalon Technologies Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Gross Profit
CA$18.4m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
17%
Theratechnologies Inc
TSX:TH
Gross Profit
$65.6m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
21%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Gross Profit
$236.4m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
99%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Willow Biosciences Inc
TSX:WLLW
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Gross Profit
CA$1.4m
CAGR 3-Years
28%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
54.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.77 CAD
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Gross Profit?
Gross Profit
18.4m CAD

Based on the financial report for Jun 30, 2025, Covalon Technologies Ltd's Gross Profit amounts to 18.4m CAD.

What is Covalon Technologies Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
17%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Covalon Technologies Ltd have been 5% over the past three years , 5% over the past five years , and 17% over the past ten years .

Back to Top